Dr Miroslav Ravic CEO MGB Biopharma

MGB Biopharma announces successful outcome from phase II clinical study on MGB-BP-3 for the treatment of Clostridium difficile infection

Mark McIntyre blog

MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, today announces the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI). The study confirms that the drug has the potential to become the new gold standard, first-line treatment for CDI. CDI is a serious and often life-threatening infection of the large intestine …

Archangels leads further investment in home-grown Scottish innovators

Mark McIntyre blog

Archangels, the Edinburgh-based business angel investment syndicate – believed to be the oldest in the world – has led investment of £6.2 million in Scottish early stage companies in the first quarter of 2020. Four tech and life sciences businesses – Blackford Analysis; Fios Genomics; Optoscribe; and Speech Graphics – were the recipients of the additional investment. £2.6 million came …

Oproscribe - Waferscale fabrication of fanout

Scottish-based Optoscribe announces investment round from Archangels, Maven and Par Equity

Mark McIntyre blog

Optoscribe Ltd, a world-leading supplier of 3D glass-based integrated photonics components, today announced that the company has closed its latest investment round. This funding round, which was led by Scottish business angel investment syndicate, Archangels, with participation from Maven Capital Partners, Par Equity and Scottish Investment Bank, will facilitate the continued expansion of the business and enable extended commercial engagement. …

Calcivis CEO Adam Christie

Edinburgh-based CALCIVIS receives Approvable Letter from FDA

Mark McIntyre blog

Edinburgh, March 5th 2020 – CALCIVIS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announces receipt of an Approvable Letter for the Premarket Approval (PMA) of its CALCIVIS® Imaging System from the US Food and Drug Administration (FDA). CALCIVIS intends to introduce this novel product in the US in 2021 with the …

Archangels Focuses on Scale-up

Spreng Thomson blog

The role of Archangels in supporting Scottish companies to scale-up will be highlighted at the investment syndicate’s annual dinner, Chorus 2018.

Sarah Hardy, Archangels

Archangels and SIB back BDD

Spreng Thomson blog

Archangels, SIB, & BDD complete a £2m funding round designed to enable BDD to scale its business, focusing on its precision timed drug delivery system.

Archangels Logo

Budget comment from Archangels

Spreng Thomson blog

David Ovens, Chief Operating Officer at Archangels, the oldest & one of the largest business angel investment syndicates in the world, comments on budget

WaveLIFT funding boost

Spreng Thomson blog

WaveLIFT Limited announces that it has secured funding of over £1 million to develop its innovative Artificial Lift pump technology for the oil and gas sector.